Day One, September 12, 2024 - MT (Mexican Pacific Time, GMT-07:00)
Day One, September 12, 2024 - MT (Mexican Pacific Time, GMT-07:00)
- Missie Scheffman - National Reimbursement Director, Astellas
- Callie Mertel - Senior Conference Producer, Informa Connect
Innovative technology can revolutionize patient support services and improve the connections among pharmaceutical companies, providers, pharmacists, and payers to not only simplify processes, but allow care teams to move away from outdated, complex systems to a more streamlined approach. The future landscape of hubs requires a hybrid approach that combines advanced technology, like AI, with the essential element of human compassion to remove barriers across the patient journey. In her session, Kimberley Chiang, Vice President, Biopharma Commercial Solutions at CoverMyMeds, will share how tech-enabled hubs paired with human expertise and empathy can significantly boost effectiveness to expedite patient access to necessary therapies and improve health outcomes for all.
- Kimberley Chiang - Vice President, Biopharma Commercial Solutions, CoverMyMeds
Kickstart the Congress with a panel discussion comprised of top industry executives working with the hub space. Engage in a comparison of experiences, best practices and benchmarking across companies of varying size and maturity.
- Josh Konetzni - Senior Vice President, Head of Business Development, VMS BioMarketing
- Marla Hogle - Senior Manager, Patient Support Services, Dexcom
- Nancy Bell - Vice President, Head of US Patient Value & Access, Takeda Oncology
- Discuss best practices in selecting an effective partner for your hub
- Understand what makes a partnership successful, specifically for a new product or single asset company
- Uncover common partnership gaps and how to catch in advance as you look at the RFP process
- Ensure that your partnership is a solid extension of your own brand to increase it’s longevity
- Alicia Dixon, MHA - Vice President, Solutions Management, COPILOT
- Jennifer Clark - Senior Director, Patient Services, Menarini Stemline
- Melissa Beatty - Executive Director, Patient Services, Zevra Therapeutics
- Renee Shiota - Senior Director, Trade, Distribution and Patient Services, Mirum Pharmaceuticals, Inc.
- Learn more about free drug, bridge and startup programs and how they can be best managed within a hub
- Understand how to integrate patient assistance within your program
- Highlight the main risks and OIG watchouts to compliantly build free drug programs
- Andrew Cerri - Group Marketing Manager, Consumer Access, Abbott Diabetes Care
Description TBA
- Discuss how industry shifts are affecting manufacturers’ ability to maintain this balance & current issues manufacturers are facing
- Hear how to optimize the value of patient access programs and how vital proper data analysis is to maintaining GTN
- Explore the balance and trade-offs between maintaining effective patient programs while retaining GTN
- Nancy Bell - Vice President, Head of US Patient Value & Access, Takeda Oncology
The choice between insourced hubs, outsourced solutions, or a strategic combination of both is a critical decision for companies seeking operational excellence. This session provides a comprehensive exploration of the key considerations surrounding insourced and hybrid hubs
- Explore advantages and challenges associated with insourced and hybrid models
- Understand strategies for achieving cost optimization through insourcing or hybrid solutions, balancing the benefits of in-house control with potential cost savings
- Examine the adaptability and flexibility afforded by insourced and hybrid hubs
- Discover the role of technology in optimizing insourced and hybrid hubs
- Alex Buell - Lead Director, Sales and Business Development, Cardinal Health™ Sonexus™ Access and Patient Support
- Naveed Masood - Head of US Launch Readiness and Patient Services, Servier